Article
A person can report that the body feels distant, the self seems altered, or the world takes on a different character. Such reports matter as descriptions of experience. They do not by themselves tell us why the change occurred, what the self ultimately is, or whether an experience reveals a spiritual truth.
Products and labels are not interchangeable
The FDA label for ketamine hydrochloride injection, marketed as KETALAR, classifies that product as an anesthetic. Esketamine nasal spray, marketed as SPRAVATO, has its own product-specific label, indications, and required monitoring in certified settings. Evidence or authorization attached to one product should not be transferred to the other as though their labels described the same medicine.[1][2]
The current labels also identify material risks, including dissociation and sedation, and specify monitoring requirements for the labeled products. Those facts belong beside discussion of unusual experience: the same term that describes a reported shift may also name a clinically relevant effect. This essay describes research and labels; it does not give medical directions.[1][2]
A report is a record of experience
In a phenomenological study of 15 healthy volunteers, Pomarol-Clotet and colleagues documented varied psychological effects after ketamine administration. The authors noted that familiar labels such as depersonalization and derealization did not capture every reported feature. The study is useful for describing a small group’s accounts, not for declaring how every person experiences ketamine or what those experiences mean.[3]
A report can be vivid, unsettling, or meaningful to the person who had it. Its importance as a first-person account does not make it a measurement of an external spiritual realm. Nor does a change in self-feeling settle whether the self is a stable entity, a process, or a philosophical construction. Those are different questions, requiring different kinds of argument and evidence.
Research models remain specific to their tests
Hack and colleagues studied 13 nonclinical participants using particular tasks and measures. Their paper connects task-specific brain-state effects with distinct altered-state dimensions. It offers a research model for the conditions studied, not a universal neural signature of dissociation or a complete account of selfhood across people and settings.[4]
Other researchers have proposed frameworks for how dissociation may relate to ketamine’s effects. Ballard and Zarate describe the question as unsettled, while Dai and colleagues offer an expanded neurocognitive account as a proposal. A perspective or model can organize questions for future work; it should not be mistaken for a settled causal mechanism or a clinical conclusion.[5][6]
Experience and explanation remain distinct
Pharmacology, neural measurements, self-reports, product regulations, and spiritual interpretation can inform one conversation, but one cannot stand in for all the others. A changed sense of self is an experience to describe and study. The inference that it proves a universal theory of the self or a spiritual truth reaches beyond the evidence summarized here.[3][4][5]
How should a careful account keep a changed sense of self distinct from a claim about what the self ultimately is?